Literature DB >> 19897559

Variability in the prevalence of premenstrual asthma.

A Pereira Vega1, J L Sánchez Ramos, J A Maldonado Pérez, F J Alvarez Gutierrez, J M Ignacio García, R Vázquez Oliva, P Romero Palacios, J M Bravo Nieto, I Sánchez Rodríguez, F Gil Muñoz.   

Abstract

Our aim is to analyse the differences in the prevalence of premenstrual asthma (PMA) according to a set of criteria, the relationship between them and the influence of asthma severity. The answer "Yes" to "Does your asthma get worse before menstruation?" was considered subjective PMA. A daily respiratory symptoms register of fertile asthmatic females was taken during two consecutive menstrual cycles. For the semi-objective diagnosis, an exacerbation of > or =20% was required in the symptoms register. Objective diagnosis was a premenstrual worsening of > or =20% of peak flow. We selected 103 patients. Subjective premenstrual deterioration was perceived in 43.7%. The semi-objective deterioration of symptoms in the first cycle occurred in 44.7%, and in 22.3% in both cycles. A total of 54.3% of females with semi-objective criteria in the first cycle perceived a subjective deterioration of symptoms, versus 35.1% of those without semi-objective criteria (p = 0.05). PMA was present at all levels of asthma severity, with no clear link to the degree of severity. The detection of PMA prevalence, the subjective perception of this deterioration and its presence at all levels of asthma severity lead us to urge research into possible premenstrual deterioration in all fertile asthmatic females.

Entities:  

Mesh:

Year:  2009        PMID: 19897559     DOI: 10.1183/09031936.00045109

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  6 in total

1.  Studying forced expiratory volume at 1 second over menstrual segments in asthmatic and non-asthmatic women: assessing protocol feasibility.

Authors:  Ganesa Wegienka; Ewa Hasiec; Homer Boushey; Christine Cole Johnson; Ronald Strickler; Edward Zoratti; Suzanne Havstad
Journal:  BMC Res Notes       Date:  2012-07-06

2.  Gender-specific asthma treatment.

Authors:  Inseon S Choi
Journal:  Allergy Asthma Immunol Res       Date:  2010-11-08       Impact factor: 5.764

Review 3.  Perimenstrual asthma: from pathophysiology to treatment strategies.

Authors:  Alessandra Graziottin; Audrey Serafini
Journal:  Multidiscip Respir Med       Date:  2016-08-01

4.  Relationship Between Gender and the Effectiveness of Montelukast: An Italian/Danish Register-Based Retrospective Cohort Study.

Authors:  Maurizio Sessa; Annamaria Mascolo; Bruno D'Agostino; Antonio Casciotta; Vincenzo D'Agostino; Fausto De Michele; Mario Polverino; Giuseppe Spaziano; Mikkel Porsborg Andersen; Kristian Kragholm; Francesco Rossi; Christian Torp-Pedersen; Annalisa Capuano
Journal:  Front Pharmacol       Date:  2018-08-02       Impact factor: 5.810

Review 5.  Acute Severe Asthma in Adolescent and Adult Patients: Current Perspectives on Assessment and Management.

Authors:  Eirini Kostakou; Evangelos Kaniaris; Effrosyni Filiou; Ioannis Vasileiadis; Paraskevi Katsaounou; Eleni Tzortzaki; Nikolaos Koulouris; Antonia Koutsoukou; Nikoletta Rovina
Journal:  J Clin Med       Date:  2019-08-22       Impact factor: 4.241

Review 6.  Mechanisms, Cofactors, and Augmenting Factors Involved in Anaphylaxis.

Authors:  Rosa Muñoz-Cano; Mariona Pascal; Giovanna Araujo; M J Goikoetxea; Antonio L Valero; Cesar Picado; Joan Bartra
Journal:  Front Immunol       Date:  2017-09-26       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.